Oxazolone-Induced Enterocolitis in Zebrafish Depends on the Composition of the Intestinal Microbiota

Gastroenterology

Volumn 137, Issue 5, 2009, Pages

  Brugman, Sylvia ^a   Liu, Kit Yeng ^a   Lindenbergh Kortleve, Dicky ^a   Samsom, Janneke N ^a   Furuta, Glenn T ^b   Renshaw, Stephen A ^c   Willemsen, Rob ^a   Nieuwenhuis, Edward E S ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CHILDREN S HOSPITAL COLORADO   (United States)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; COLISTIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; MYELOPEROXIDASE; OXAZOLONE; RNA 16S; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDETES; COLON INJURY; COLON MUCOSA; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENTEROCOLITIS; EOSINOPHIL; FUSOBACTERIA; GOBLET CELL; GRANULOCYTE; INFLAMMATORY INFILTRATE; INTESTINE FLORA; LYMPHOCYTIC INFILTRATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEOBACTERIA; WILD TYPE; ZEBRA FISH;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTI-BACTERIAL AGENTS; COLISTIN; DISEASE MODELS, ANIMAL; ENTEROCOLITIS; INTESTINES; OXAZOLONE; VANCOMYCIN; ZEBRAFISH;

EID: 70350093612     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.07.069     Document Type: Article

References (53)

1. Sartor R.B. Microbial influences in inflammatory bowel diseases. Gastroenterology 134 (2008) 577-594
2. Hugot J.P., Chamaillard M., Zouali H., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
3. Maeda S., Hsu L.C., Liu H., et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307 (2005) 734-738
4. Brannigan A.E., O'Connell P.R., Hurley H., et al. Neutrophil apoptosis is delayed in patients with inflammatory bowel disease. Shock 13 (2000) 361-366
5. Marks D.J., Harbord M.W., MacAllister R., et al. Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet 367 (2006) 668-678
6. Chin A.C., and Parkos C.A. Neutrophil transepithelial migration and epithelial barrier function in IBD: potential targets for inhibiting neutrophil trafficking. Ann N Y Acad Sci 1072 (2006) 276-287
7. Naito Y., Takagi T., and Yoshikawa T. Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease. J Gastroenterol 42 (2007) 787-798
8. Kantari C., Pederzoli-Ribeil M., and Witko-Sarsat V. The role of neutrophils and monocytes in innate immunity. Contrib Microbiol 15 (2008) 118-146
9. Kuhl A.A., Kakirman H., Janotta M., et al. Aggravation of different types of experimental colitis by depletion or adhesion blockade of neutrophils. Gastroenterology 133 (2007) 1882-1892
10. Debrosse C.W., and Rothenberg M.E. Allergy and eosinophil-associated gastrointestinal disorders (EGID). Curr Opin Immunol 20 (2008) 703-708
11. Rothenberg M.E., and Hogan S.P. The eosinophil. Annu Rev Immunol 24 (2006) 147-174
12. Furuta G.T., Nieuwenhuis E.E., Karhausen J., et al. Eosinophils alter colonic epithelial barrier function: role for major basic protein. Am J Physiol Gastrointest Liver Physiol 289 (2005) G890-G897
13. Darfeuille-Michaud A., Boudeau J., Bulois P., et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127 (2004) 412-421
14. Balish E., and Warner T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol 160 (2002) 2253-2257
15. Wei B., Huang T., Dalwadi H., Sutton C.L., Bruckner D., and Braun J. Pseudomonas fluorescens encodes the Crohn's disease-associated I2 sequence and T-cell superantigen. Infect Immun 70 (2002) 6567-6575
16. Sartor R.B. Antibiotics as therapeutic agents in Crohn's disease. In: Bayless T.M., and Hanauer S.B. (Eds). Advanced therapy of IBD (2001), Decker Inc, London 359-362
17. Greenbloom S.L., Steinhart A.H., and Greenberg G.R. Combination ciprofloxacin and metronidazole for active Crohn's disease. Can J Gastroenterol 12 (1998) 53-56
18. Ursing B., Alm T., Barany F., et al. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result. Gastroenterology 83 (1982) 550-562
19. Burke D.A., Axon A.T., Clayden S.A., Dixon M.F., Johnston D., and Lacey R.W. The efficacy of tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Ther 4 (1990) 123-129
20. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A.C., and Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75 (1993) 253-261
21. Sellon R.K., Tonkonogy S., Schultz M., et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66 (1998) 5224-5231
22. Hoentjen F., Tonkonogy S.L., Qian B.F., Liu B., Dieleman L.A., and Sartor R.B. CD4(+) T lymphocytes mediate colitis in HLA-B27 transgenic rats monoassociated with nonpathogenic Bacteroides vulgatus. Inflamm Bowel Dis 13 (2007) 317-324
23. Dieleman L.A., Goerres M.S., Arends A., et al. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52 (2003) 370-376
24. Kim S.C., Tonkonogy S.L., Albright C.A., et al. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128 (2005) 891-906
25. Hoentjen F., Harmsen H.J., Braat H., et al. Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene deficient mice. Gut 52 (2003) 1721-1727
26. Rath H.C., Schultz M., Freitag R., et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun 69 (2001) 2277-2285
27. Card T., Logan R.F., Rodrigues L.C., and Wheeler J.G. Antibiotic use and the development of Crohn's disease. Gut 53 (2004) 246-250
28. Perencevich M., and Burakoff R. Use of antibiotics in the treatment of inflammatory bowel disease. Inflamm Bowel Dis 12 (2006) 651-664
29. Nieuwenhuis E.E., Visser M.R., Kavelaars A., et al. Oral antibiotics as a novel therapy for arthritis: evidence for a beneficial effect of intestinal Escherichia coli. Arthritis Rheum 43 (2000) 2583-2589
30. Boirivant M., Fuss I.J., Chu A., and Strober W. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 188 (1998) 1929-1939
31. Heller F., Fuss I.J., Nieuwenhuis E.E., Blumberg R.S., and Strober W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17 (2002) 629-638
32. Nieuwenhuis E.E., Neurath M.F., Corazza N., et al. Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc Natl Acad Sci U S A 99 (2002) 16951-16956
33. Rawls J.F., Mahowald M.A., Ley R.E., and Gordon J.I. Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell 127 (2006) 423-433
34. Rawls J.F., Mahowald M.A., Goodman A.L., Trent C.M., and Gordon J.I. In vivo imaging and genetic analysis link bacterial motility and symbiosis in the zebrafish gut. Proc Natl Acad Sci U S A 104 (2007) 7622-7627
35. Trede N.S., Langenau D.M., Traver D., Look A.T., and Zon L.I. The use of zebrafish to understand immunity. Immunity 20 (2004) 367-379
36. Love D.R., Lan C.C., Dodd A., Shelling A.N., McNabb W.C., and Ferguson L.R. Modeling inflammatory bowel disease: the zebrafish as a way forward. Expert Rev Mol Diagn 7 (2007) 177-193
37. Ng A.N., de Jong-Curtain T.A., Mawdsley D.J., et al. Formation of the digestive system in zebrafish: III. Intestinal epithelium morphogenesis. Dev Biol 286 (2005) 114-135
38. Flores M.V., Hall C.J., Davidson A.J., et al. Intestinal differentiation in zebrafish requires Cdx1b, a functional equivalent of mammalian Cdx2. Gastroenterology 135 (2008) 1665-1675
39. Wienholds E., Schulte-Merker S., Walderich B., and Plasterk R.H. Target-selected inactivation of the zebrafish rag1 gene. Science 297 (2002) 99-102
40. Renshaw S.A., Loynes C.A., Trushell D.M., Elworthy S., Ingham P.W., and Whyte M.K. A transgenic zebrafish model of neutrophilic inflammation. Blood 108 (2006) 3976-3978
41. Wallace K.N., Akhter S., Smith E.M., Lorent K., and Pack M. Intestinal growth and differentiation in zebrafish. Mech Dev 122 (2005) 157-173
42. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., and Medzhitov R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118 (2004) 229-241
43. van der Sar A.M., Stockhammer O.W., van der Laan C., Spaink H.P., Bitter W., and Meijer A.H. MyD88 innate immune function in a zebrafish embryo infection model. Infect Immun 74 (2006) 2436-2441
44. Bates J.M., Akerlund J., Mittge E., and Guillemin K. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2 (2007) 371-382
45. Dave S.H., Tilstra J.S., Matsuoka K., et al. Amelioration of chronic murine colitis by peptide-mediated transduction of the IkappaB kinase inhibitor NEMO binding domain peptide. J Immunol 179 (2007) 7852-7859
46. Elson G., Dunn-Siegrist I., Daubeuf B., and Pugin J. Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood 109 (2007) 1574-1583
47. Nieuwenhuis E.E., Matsumoto T., Lindenbergh D., et al. Cd1d-dependent regulation of bacterial colonization in the intestine of mice. J Clin Invest 119 (2009) 1241-1250
48. te Velde A.A., de Kort F., Sterrenburg E., et al. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease. Inflamm Bowel Dis 13 (2007) 325-330
49. Strober W., Fuss I.J., and Blumberg R.S. The immunology of mucosal models of inflammation. Annu Rev Immunol 20 (2002) 495-549
50. Zhong W., Kolls J.K., Chen H., McAllister F., Oliver P.D., and Zhang Z. Chemokines orchestrate leukocyte trafficking in inflammatory bowel disease. Front Biosci 13 (2008) 1654-1664
51. Chen L.C., Chen J.Y., Hour A.L., Shiau C.Y., Hui C.F., and Wu J.L. Molecular cloning and functional analysis of zebrafish (Danio rerio) chemokine genes. Comp Biochem Physiol B Biochem Mol Biol 151 (2008) 400-409
52. Lundberg S., Lindholm J., Lindbom L., Hellstrom P.M., and Werr J. Integrin alpha2beta1 regulates neutrophil recruitment and inflammatory activity in experimental colitis in mice. Inflamm Bowel Dis 12 (2006) 172-177
53. Kusugami K., Ina K., Ando T., Hibi K., Nishio Y., and Goto H. Immunomodulatory therapy for inflammatory bowel disease. J Gastroenterol 39 (2004) 1129-1137